Literature DB >> 12850647

The memorial symptom assessment scale: modified for use in understanding family caregivers' perceptions of cancer patients' symptom experiences.

Michelle M Lobchuk1.   

Abstract

The purpose of this study was to determine whether the Memorial Symptom Assessment Scale (MSAS) could serve as a feasible, reliable, and valid tool for use in assessing the reports of 98 family caregivers (FC) on the symptom experiences of advanced stage cancer patients. The MSAS consists of subscales that describe psychological symptom distress (PSYCH), physical symptom distress (PHYS), and global symptom distress (Global Distress Index [MSAS-GDI]). The majority of FCs was able to respond to 32 MSAS symptom items; however, the greatest difficulty in FC responding occurred on the 'sexual interest' item. The mean PSYCH score was 1.42 (SD=0.83), the mean PHYS score was 0.96 (SD=0.67), and the mean MSAS-GDI was 1.46 (SD=0.24). Internal consistency was high in the PHYS (alpha=0.84), PSYCH (alpha=0.82), and MSAS-GDI (alpha=0.84) subscales. The average item-scale correlation ranged between r=0.50 and 0.60, indicating that the items were moderately to strongly correlated with the respective total subscales. The average inter-item correlation ranged between r=0.30 and 0.45, indicating that the items were moderately correlated with each other on the respective subscales. Good to excellent intraclass correlations (ICC) with patients' ordinal ratings support the concurrent validity and utility of the PHYS and MSAS-GDI subscales in FC populations who care for cancer patients in the home setting. Depending on the symptom, a range of slight to substantial Kappa values on dichotomous PHYS and PSYCH items, and fair ICC values on the ordinal PSYCH subscale provide questionable validity in FC populations caring for cancer patients.

Entities:  

Mesh:

Year:  2003        PMID: 12850647     DOI: 10.1016/s0885-3924(03)00205-7

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  10 in total

1.  Congruence in symptom assessment between hepatocellular carcinoma patients and their primary family caregivers in China.

Authors:  Xiang-Yan Liu; Jie Shen; Zhi-Xia Ye; Juan Li; Wen-Ting Cao; Chen Hu; Yan Xu
Journal:  Support Care Cancer       Date:  2013-05-08       Impact factor: 3.603

2.  Identifying the Prevalence and Correlates of Caregiver-Reported Symptoms in Home Hospice Patients at the End of Life.

Authors:  Veerawat Phongtankuel; Jeanne A Teresi; Joseph P Eimicke; Jian X Kong; Ronald D Adelman; Holly G Prigerson; Sara J Czaja; Ariel Shalev; Ritchell Dignam; Rosemary Baughn; M Cary Reid
Journal:  J Palliat Med       Date:  2019-12-23       Impact factor: 2.947

Review 3.  Qualitative research into the symptom experiences of adult cancer patients after treatments: a systematic review and meta-synthesis.

Authors:  A E Bennion; A Molassiotis
Journal:  Support Care Cancer       Date:  2012-09-13       Impact factor: 3.603

4.  Influence of Menopausal Status on the Symptom Experience of Women Before Breast Cancer Surgery.

Authors:  Melissa Mazor; Janine K Cataldo; Kathryn Lee; Anand Dhruva; Steven M Paul; Betty J Smoot; Laura B Dunn; Jon D Levine; Judy Mastick; Yvette P Conley; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2018 Jul/Aug       Impact factor: 2.592

Review 5.  The psychometric properties of cancer multisymptom assessment instruments: a clinical review.

Authors:  Aynur Aktas; Declan Walsh; Jordanka Kirkova
Journal:  Support Care Cancer       Date:  2015-04-19       Impact factor: 3.603

6.  Symptom profiles in children with advanced cancer: Patient, family caregiver, and oncologist ratings.

Authors:  Donna S Zhukovsky; Cathy L Rozmus; Rhonda S Robert; Eduardo Bruera; Robert J Wells; Gary B Chisholm; Julio A Allo; Marlene Z Cohen
Journal:  Cancer       Date:  2015-07-28       Impact factor: 6.860

7.  Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.

Authors:  Marlise Poolman; Jessica Roberts; Stella Wright; Annie Hendry; Nia Goulden; Emily Af Holmes; Anthony Byrne; Paul Perkins; Zoe Hoare; Annmarie Nelson; Julia Hiscock; Dyfrig Hughes; Julie O'Connor; Betty Foster; Liz Reymond; Sue Healy; Penney Lewis; Bee Wee; Rosalynde Johnstone; Rossela Roberts; Anne Parkinson; Sian Roberts; Clare Wilkinson
Journal:  Health Technol Assess       Date:  2020-05       Impact factor: 4.014

8.  Bereaved family member perceptions of patient-focused family-centred care during the last 30 days of life using a mortality follow-back survey: does location matter?

Authors:  Fred Burge; Beverley Lawson; Grace Johnston; Yukiko Asada; Paul F McIntyre; Eva Grunfeld; Gordon Flowerdew
Journal:  BMC Palliat Care       Date:  2014-05-14       Impact factor: 3.234

9.  CARer-ADministration of as-needed subcutaneous medication for breakthrough symptoms in homebased dying patients (CARiAD): study protocol for a UK-based open randomised pilot trial.

Authors:  Marlise Poolman; Jessica Roberts; Anthony Byrne; Paul Perkins; Zoe Hoare; Annmarie Nelson; Julia Hiscock; Dyfrig Hughes; Betty Foster; Julie O'Connor; Liz Reymond; Sue Healy; Rossela Roberts; Bee Wee; Penney Lewis; Rosalynde Johnstone; Sian Roberts; Emily Holmes; Stella Wright; Annie Hendry; Clare Wilkinson
Journal:  Trials       Date:  2019-02-07       Impact factor: 2.279

10.  Caregiver-Reported Quality Measures and Their Correlates in Home Hospice Care.

Authors:  Veerawat Phongtankuel; M C Reid; Sara J Czaja; Jeanne Teresi; Joseph P Eimicke; Jian X Kong; Holly Prigerson; Ariel Shalev; Ritchell Dignam; Rosemary Baughn; Ronald D Adelman
Journal:  Palliat Med Rep       Date:  2020-07-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.